Clinical Trials on Rheumatism in Japan

Total 224 results

Zimmer Biomet

Completed

Vanguard TKA With KneeAlign 2 and Without KneeAlign 2

Osteoarthritis, Knee

Japan
RS Medical
Accelerated Care Plus; Research Institute of Health and Science (RIHSE)

Completed

Patterned Electrical Neuromuscular Stimulation and Therapeutic Exercise for Osteoarthritis of the Knee: Pilot Study

Knee Osteoarthritis

Japan
Chiba University

Completed

Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis (OPTIWIT)

Arthritis, Rheumatoid

Japan
Sanofi

Completed

Safety, Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee Osteoarthritis

Knee Osteoarthritis

Japan
Pfizer

Completed

Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis

Arthritis, Rheumatoid

Japan
Eli Lilly and Company
Shionogi

Completed

An Extension Study of Duloxetine in Osteoarthritis and Knee Pain (Extension of F1J-JE-HMGX, NCT02248480)

Osteoarthritis of the Knee

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

An Extension Study of TS-152 in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Daiichi Sankyo, Inc.

Completed

AMG 162 (Denosumab) Phase 3 Study (DESIRABLE Study) in Participants With Rheumatoid Arthritis on Disease-modifying Antirheumatic Drugs (DMARDs) Treatment (DESIRABLE)

Rheumatoid Arthritis

Japan
Pfizer

Completed

Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan

Rheumatoid Arthritis

Japan
Eli Lilly and Company
Shionogi

Completed

A Study of Duloxetine in Fibromyalgia

Fibromyalgia

Japan
Pfizer

Active, not recruiting

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)

Rheumatoid Arthritis

Japan
Pfizer

Completed

Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Japan Biological Agent Study Integrated Consortium

Completed

Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in Japan (JESMR)

Rheumatoid Arthritis

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study of MP-435 in Combination With Methotrexate (MTX) in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis.

Rheumatoid Arthritis

Japan
Eli Lilly and Company
Shionogi

Completed

An Extension Study of Duloxetine in Fibromyalgia (Extension of F1J-JE-HMGZ, NCT01552057)

Fibromyalgia

Japan
Pfizer

Completed

Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance] (Enbrel-JIA)

Juvenile Idiopathic Arthritis

Japan
Zimmer Biomet

Recruiting

ROSA Knee Intraoperative Planning Flexibility Study (IntraOP)

Rheumatoid Arthritis | Osteo Arthritis Knee

Japan
Eli Lilly and Company
Shionogi

Completed

A Study of Duloxetine (LY248686) in Participants With Chronic Osteoarthritis and Knee Pain in Japan

Osteoarthritis of the Knee

Japan
Novartis Pharmaceuticals

Completed

Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants

Osteoarthritis | Knee

Japan
Zimmer Biomet
Biomet Japan, Inc.

Completed

Review on Minimally Invasive Skin Incision in Vanguard PS Artificial Knee Joint System

Gonarthrosis Patients Who Need Artificial Knee Joint Total Replacement

Japan
Stryker Japan K.K.

Completed

Navigation With X3 vs Non-Navigation With X3 Study

Degenerative Joint Disease

Japan
Atsushi Kawakami
AbbVie GK.

Recruiting

Discontinuation of Methotrexate in Rheumatoid Arthritis Patients Achieving Clinical Remission by Treatment With Upadacitinib Plus Methotrexate (DOPPLER)

Rheumatoid Arthritis | Biomarker | JAK Inhibitor | Musculoskeletal Ultrasound

Japan
Shinshu University

Recruiting

Usefulness of Non TNF Usage in RA Patients

Rheumatoid Arthritis

Japan
Shinshu University

Recruiting

Examination of Efficacy and Safety of Baricitinib in RA Patients

Rheumatoid Arthritis

Japan
Sanofi
Regeneron Pharmaceuticals

Completed

Single Ascending Dose Study of Safety and Tolerability of Sarilumab and Methotrexate in Japanese Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Nichi-Iko Pharmaceutical Co., Ltd.

Completed

A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Sanofi
Regeneron Pharmaceuticals

Completed

Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Shinshu University
Showa Inan General Hospital

Recruiting

Evaluation of the Condition of Rheumatoid Arthritis After Treatment

Rheumatoid Arthritis

Japan
Nichi-Iko Pharmaceutical Co., Ltd.

Completed

Study of NI-071 in Comparison With Remicade in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Saitama Medical University
Keio University

Unknown

Bucillamine Study of Holding Remission After Infliximab Dose-off

Rheumatoid Arthritis

Japan
Synthes GmbH
Johnson & Johnson K.K. Medical Company

Completed

Treatment of Medial Compartmental Osteoarthritis Grade 1-4 With TomoFix™ Small or Conservatively

Osteoarthritis, Knee | Osteonecrosis

Japan
Atsushi Kawakami
Gilead Sciences

Recruiting

Efficacy and Safety of Selective JAK 1 Inhibitor Filgotinib in Active Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate (TRANSFORM)

Rheumatoid Arthritis | Biomarker | JAK Inhibitor | Musculoskeletal Ultrasound | IL-6 Inhibitor

Japan
Omron Healthcare Co., Ltd.
Western Michigan University

Unknown

The Effects of Transcutaneous Electrical Nerve Stimulation on People With Knee Osteoarthritis (OA) and or Chronic Pain

Knee Pain

Japan
Stryker Japan K.K.

Completed

Scorpio Non Restricted Geometry (NRG) Study in Japan

Osteoarthritis | Rheumatoid Arthritis

Japan
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

Long-Term Outcomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settings

Rheumatoid Arthritis

Japan
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL

Rheumatoid Arthritis

Japan
Kobe University

Unknown

Quality of Sleep in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Zimmer Biomet

Completed

Persona TKA With iASSIST Knee System and iASSIST Knee System

Osteoarthritis, Knee

Japan
Zimmer Biomet

Completed

A Study on M2a Magnum Total Hip Arthroplasty

Avascular Necrosis | Degenerative Joint Disease

Japan
DePuy Orthopaedics
Johnson & Johnson K.K. Medical Company

Completed

DSJ-2016-07 ATTUNE® Cementless CR RP Japan

Osteoarthritis

Japan
Keio University
Saitama Medical University

Unknown

Efficacy and Safety of Adalimumab 80 mg Every Other Week With Methotrexate

Rheumatoid Arthritis

Japan
Shinshu University

Recruiting

To Examine Whether or Not the Primary Causes of OA or RA Might be Bone Alterations

Osteoarthritis of Multiple Joints | Progression of Rheumatoid Arthritis

Japan
Stryker Japan K.K.

Unknown

Flex Intramedullary Rod Study

Arthroplasty, Replacement, Knee | Osteoarthritis of the Knee

Japan
LG Life Sciences
Mochida Pharmaceutical Company, Ltd.

Unknown

A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Arthritis, Rheumatoid

Japan, Korea, Republic of
LG Life Sciences
Mochida Pharmaceutical Company, Ltd.

Completed

A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Arthritis, Rheumatoid

Japan, Korea, Republic of
Fuji Yakuhin Co., Ltd.
Mochida Pharmaceutical Company, Ltd.

Completed

Study of FYU-981 in Hyperuricemia With or Without Gout

Hyperuricemia With or Without Gout

Japan
Mochida Pharmaceutical Company, Ltd.
Fuji Yakuhin Co., Ltd.

Completed

Febuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout

Hyperuricemia With or Without Gout

Japan
Fuji Yakuhin Co., Ltd.
Mochida Pharmaceutical Company, Ltd.

Completed

Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout

Hyperuricemia With or Without Gout

Japan
Mochida Pharmaceutical Company, Ltd.
Fuji Yakuhin Co., Ltd.

Completed

Study of FYU-981 in Hyperuricemic Outpatients With or Without Gout (Effect on Two Hyperuricemic Types)

Hyperuricemia With or Without Gout

Japan

3

Subscribe